1 of 5
2 of 5
3 of 5
4 of 5
5 of 5
Monoclonal Mouse anti‑Human G6PD Antibody (clone 5E+12, IHC, WB) LS‑C758976
Monoclonal Mouse anti‑Human G6PD Antibody (clone 5E+12, IHC, WB) LS‑C758976
Antibody:
G6PD Mouse anti-Human Monoclonal (5E+12) Antibody
Application:
IHC, WB, Flo
Format:
Unconjugated, Unmodified
Overview
Antibody:
G6PD Mouse anti-Human Monoclonal (5E+12) Antibody
Application:
IHC, WB, Flo
Format:
Unconjugated, Unmodified
Specifications
Description
G6PD antibody LS-C758976 is an unconjugated mouse monoclonal antibody to human G6PD. Validated for Flow, IHC and WB.
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Immunogen
Purified recombinant fragment of human G6PD expressed in E. coli.
Applications
- IHC (1:200 - 1:1000)
- Western blot (1:500 - 1:2000)
- Flow Cytometry (1:200 - 1:400)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Usage
Applications should be user optimized.
Presentation
Ascites, 0.03% sodium azide
Storage
Short term: 4°C; Long term: -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA
Species:
Human, Monkey
Applications:
IHC, IHC - Paraffin, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Human, Monkey, Xenopus
Applications:
IHC, IHC - Paraffin, Western blot, ELISA, Peptide Enzyme-Linked Immunosorbent Assay
Species:
Yeast
Applications:
IHC, Western blot, ELISA, Immunoelectrophoresis
Species:
Human
Applications:
Western blot
Reactivity:
Human
Range:
0.625-40 ng/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 10/31/2024